A protective effect has been suggested for androgen receptor (AR) activation both in male and females [98,99] as well as a suppressive action on the generation of bioactive lipids from polyunsaturated fatty acids (PUFAs), even though a PCOS specific elevation in phosphatidylcholine (PC) was ascribed [100]. The gene discussed is AR; the disease is polycystic ovary syndrome.